NATURES SUNSHINE PRODUCTS INC financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data NATURES SUNSHINE PRODUCTS INC files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	341	342	365	362	385	444	422	445	454	480
Cost of revenue	90.9	91	95.7	93.9	101	115	122	124	130	132
Gross profit	250	251	269	268	284	329	300	321	325	348
Research and development	3.2	3.4	2.8	2.1	1.5	1.4	1.5	1.6	1.7	1.9
Selling, general and administrative	120	130	138	129	131	154	153	167	164	178
Operating income	10	1.39	5.35	16.1	21.5	34.7	16.3	18.7	20.1	24.7
Interest expense	0.02	0.29	0.39	0.04	0.1	0.25	0.25	0.07	0.15	0.1
Other non-operating income	-0.77	1.84	-2.15	-0.48	1.34	-2.85	-1.04	1.45	-1.67	5.07
Pre-tax income	9.27	3.22	3.2	15.6	22.8	31.8	15.2	20.2	18.4	29.8
Income tax	8.59	17	4.4	8.71	-0.14	1.62	14.7	3.79	10.5	9.36
Income from continuing operations	2.14	-12.9
Net income to minority interests	-1.46	-0.88	-0.35	0.16	1.62	1.35	0.94	1.34	0.2	0.93
Net income	2.14	-12.9	-0.85	6.77	21.3	28.9	-0.39	15.1	7.7	19.5
EBITDA	14.8	10	15.2	26.7	32.2	45.8	27.3	30.6	34.3	38.6
EPS, basic	0.11	-0.69	-0.04	0.35	1.09	1.45	-0.02	0.79	0.41	1.08
EPS, diluted	0.11	-0.69	-0.04	0.34	1.07	1.42	-0.02	0.77	0.40	1.06
Shares, basic (weighted)	18.7	18.9	19.1	19.3	19.5	19.9	19.3	19.1	18.6	18
Shares, diluted (weighted)	19.1	18.9	19.1	19.7	20	20.3	19.3	19.5	19.1	18.5
Dividend per share	0.40	0.10	0.00	0.00	0.00	1.00	0.00

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	32.3	42.9	50.6	53.6	92.1	86.2	60	82.4	84.7	93.9
Receivables	7.74	8.89	7.75	7.32	7.38	8.87	14.1	8.83	9.48	8.6
Inventory	47.6	44	42	46.7	47.7	60.9	67.9	66.9	59.4	68.3
Other current assets	4.59	5.67	6.39	5.09	6.94	8.76	7.42	7.72	6.96	8.04
Total current assets	94.5	103	107	113	154	165	150	166	161	179
Property, plant and equipment	73.3	69.1	64.1	59.5	54.4	50.9	46.2	45	39.6	32.9
Lease right-of-use assets			24	20.2	20.2	18.3	16.1	13.4	12.8	17.6
Intangible assets	0.98	0.71	0.62	0.57
Other non-current assets	13.8	12.6	11.1	10.9	11.2	10.4	10.4	9.78	9.33	10.6
Total assets	206	195	193	213	249	259	230	250	241	261
Accounts payable	5.31	4.22	5.22	4.41	6.49	9.7	6.35	7.91	8.91	8.02
Accrued liabilities	24.4	25	34.8	25.5	31.7	31.6	25.6	33.2	25.4	34.1
Deferred revenue	3.67	3.35	1.2	1.27	2.09	3.69	2.26	1.79	2.77	5.84
Short-term debt	9.92	0		0	1.31	1.24	1.17	0
Total current liabilities	63	53.7	66.7	57.9	69.7	76.7	65.6	76.8	65.7	78.5
Long-term debt				0	2.42	1.17	0
Lease liabilities				20.2	16.4	15.9	13.7	10.4	10.3	15.6
Other non-current liabilities	1.99	1.24	0.71	1.17	1.31	1.18	1.05	0.64	1.35	2.91
Total liabilities	73.2	75.5	72.4	83.6	92.3	97.5	82.7	90.2	79.9	99.6
Total debt	9.92	13.2		0	3.72	2.42	1.17	0
Retained earnings	12.7	-2.07	-2.07	4.69	26	35	34.6	49.7	57.4	76.9
Other comprehensive income	-11.3	-10.1	-11.1	-11.2	-9.96	-10.2	-13.3	-15.3	-16.7	-17.6
Minority interests	1.29	0.41	0.06	0.23	1.85	3.2	4.14	5.48	5.68	0
Total equity	132	120	121	129	157	161	147	160	161	162
Total liabilities and equity	206	195	193	213	249	259	230	250	241	261
Shares outstanding	18.8	18.9	19.2	19.4	19.7	19.7	19.1	18.9	18.5	17.5

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	0.68	-13.8	-1.2	6.93	23	30.2	0.55	16.4	7.89	20.5
Depreciation and amortization	4.81	8.63	9.81	10.6	10.7	11.2	11	11.8	14.2	13.8
Stock-based compensation	3.22	2.22	2.17	2.12	3.79	3.73	2.9	4.89	4.79	5.78
Deferred income tax	0.76	14.1	-0.08	4.28	-4.36	-4.13	7.99	-8.06	-1.66	-2.27
Change in receivables	-0.34	-1.24	0.19	0.38	0.11	-1.68	-5.94	4.92	-1.12	1.02
Change in inventory	-9.57	5.18	1.07	-4.87	-0.15	-14.5	-8.84	1	5.56	-7.82
Change in payables	-0.94	-1.12	1.04	-0.96	2.09	3.08	-2.8	1.42	1.09	-1.8
Cash from operations	3.42	10.5	21.8	8.55	37.7	34.6	0.71	41.2	25.3	35.3
Capital expenditures	-11	-5.5	-4.83	-5.1	-4.91	-6.67	-7.63	-10.5	-11	-6.48
Sales and maturities of investments	0.01	1.78	0
Cash from investing	-11.5	-3.2	0.21	-5.1	-4.91	-6.61	-7.63	-10.5	-11	-6.48
Debt issued	0	19.2	68.3
Debt repaid	0	-6	-81.5
Stock issued	0
Share buybacks	0	0			0	-7.43	-13.6	-6.4	-8.86	-16.3
Dividends paid	-7.51	-1.85	0		0	-19.9	0
Cash from financing	-0.29	1.57	-12.2	-0.06	3.88	-31.7	-16.2	-7.96	-9.91	-23.8
Exchange rate effect	-0.74	1.73	-2.12	-0.39	1.81	-2.16	-2.99	-0.45	-2.1	4.12
Net change in cash	-9.14	10.6	7.73	2.99	38.4	-5.89	-26.2	22.3	2.33	9.19
Free cash flow	-7.61	5.02	17	3.44	32.8	27.9	-6.92	30.7	14.3	28.8
Interest paid	0.25	0.26	0.4	0.06	0.09	0.2	0.26	0.54	0.12	0.1
Income taxes paid	3.59	4.6	3.54	6.86	4.83	6.22	5.61	9.26	14.8	12.5

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $12.92 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	73.2%	Gross profit / revenue.
Operating margin	6.0%	Operating income / revenue.
EBITDA margin	8.7%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	5.8%	Pre-tax income / revenue.
Net margin	3.7%	Net income / revenue.
FCF margin	3.7%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	5.6%	Cash from operations / revenue.
Effective tax rate	34.8%	Income tax / pre-tax income, when pre-tax income is positive.
Return on assets (ROA)	7.0%	Net income / average total assets.
SG&A / revenue	37.1%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	1.3%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	1.9%	Capital expenditures / revenue.
D&A / revenue	2.7%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	5.7%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	4.4%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	4.5%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	7.1%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	5.1%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	4.1%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	23.1%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	15.0%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	2.9%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	12.5%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	12.2%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	3.7%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	153.7%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 5y	-1.8%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	165.0%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 5y	-0.2%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	39.6%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	267.8%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	-1.3%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	101.3%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 5y	-2.5%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	8.4%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	4.4%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	0.9%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-3.3%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-1.5%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-1.5%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	2.60x	Current assets / current liabilities.
Quick ratio	1.40x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	1.20x	(Cash + short-term investments) / current liabilities.
Liabilities / assets	34.8%	Total liabilities / total assets.
Interest coverage	208x	Operating income / interest expense.
Working capital	$109.7M	Current assets - current liabilities.

Efficiency

Metric	Value	How it is calculated
Asset turnover	1.89x	Revenue / average total assets.
Fixed asset turnover	15.9x	Revenue / average property, plant and equipment.
Inventory turnover	1.84x	Cost of revenue / average inventory.
Days inventory	198 days	365 x average inventory / cost of revenue.
Receivables turnover	35.5x	Revenue / average receivables.
Days sales outstanding	10 days	365 x average receivables / revenue.
Days payables	21 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	187 days	Days inventory + days sales outstanding - days payables.
FCF conversion	99.9%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	33.9%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$0.99	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$26.83	Revenue / diluted weighted shares.
FCF per share	$0.99	Free cash flow / diluted weighted shares.
Operating cash flow per share	$1.49	Cash from operations / diluted weighted shares.
Cash per share	$4.68	(Cash + short-term investments) / shares outstanding.
Buybacks / FCF	36.0%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$227.3M	Share price x shares outstanding.
Enterprise value	$144.8M	Market cap + total debt - cash - short-term investments.
P/E	12.6x	Market cap / net income. Only when net income is positive.
P/S	0.46x	Market cap / revenue.
P/FCF	12.6x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	8.31x	Market cap / cash from operations, when positive.
EV/Sales	0.29x	Enterprise value / revenue.
EV/EBIT	4.94x	Enterprise value / operating income, when both are positive.
EV/EBITDA	3.39x	Enterprise value / EBITDA, when both are positive.
EV/FCF	8.01x	Enterprise value / free cash flow, when both are positive.
FCF yield	8.0%	Free cash flow / market cap.
Earnings yield	8.0%	Net income / market cap (the inverse of P/E).
Shareholder yield	2.9%	(Dividends paid + share buybacks) / market cap.

What was NATURES SUNSHINE PRODUCTS INC's revenue in fiscal 2025?

NATURES SUNSHINE PRODUCTS INC reported revenue of $480.1M for fiscal 2025, 5.7% higher than the year before.

Was NATURES SUNSHINE PRODUCTS INC profitable in fiscal 2025?

Yes. Net income was $19.5M, a net margin of 4.1%.

How much free cash flow did NATURES SUNSHINE PRODUCTS INC generate in fiscal 2025?

Cash from operations of $35.3M minus capital expenditures of $6.5M left free cash flow of $28.8M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to NATURES SUNSHINE PRODUCTS INC